valitorbio.com - Leadership | VLTR-557 | AMD | Valitor

Description: Valitor is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact. VLTR-557, is in development to become as a long-acting treatment for wet age-related macular degeneration (AMD)

Example domain paragraphs

Technology

Engineering better medicines. Conquering drug limitations.   About About Valitor Valitor is conquering limitations of established drug targets by leveraging its multi-valent biopolymer technology to maximize benefits for patients.

The company is engineering disruptive medicines that optimize how and where disease mechanisms are targeted to produce the most significant clinical impact.

Links to valitorbio.com (5)